Milton S. Hershey Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Milton S. Hershey Medical Center sits in the top decile of US sponsors by registered trial count (#93 of 15,742 sponsors by registered trial count).

396 total trials 55 currently recruiting 255 completed early-phase tilt top decile by trial count

Milton S. Hershey Medical Center: 396 sponsored US clinical trials, 55 recruiting.

Milton S. Hershey Medical Center sponsors 396 registered US clinical trials on ClinicalTrials.gov, 55 of them currently recruiting, and 255 completed. 46 of these trials are in Phase 3-4 (later-stage) and 73 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Child Abuse, with 4 trials.

Top-decile sponsor footprint

Milton S. Hershey Medical Center ranks in the top decile of sponsors by registered trial count (#93 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 39/100

255 of 320 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

396 total, page 8 of 8

COMPLETED

Validation of Hand Held Indirect Calorimeter in Overweight and Obese Patients

NCT00670969

COMPLETED

Operatively Treated Open Pilon Fractures

NCT00689429

COMPLETED NA

Influence of Selenium on Prostate Cancer Related Biomarkers

NCT01112449

COMPLETED

Acetabular Fractures of Both Columns

NCT00676611

COMPLETED Phase 3

Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)

NCT00565266

TERMINATED Phase 1

Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer

NCT00702572

TERMINATED Phase 2

Treatment of Advanced Head and Neck Cancer

NCT00982696

COMPLETED Phase 1

Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer

NCT00565487

COMPLETED Phase 1

Cytomegalovirus (CMV) Specific Cytotoxic T Lymphocytes (CTL) When Used for Prophylaxis Against CMV in Recipients of Allogeneic, T Cell Depleted Stem Cell Transplants

NCT00673868

COMPLETED NA

Pilot Study of the National Colorectal Cancer Roundtable Toolbox (NCCRT) to Increase Colorectal Cancer Screening Rates

NCT00503737

TERMINATED NA

Fish Oil and Biomarkers of Cardiovascular Risk

NCT00527436

COMPLETED Phase 3

The Effect of Pseudoephedrine on Rhinitis and Sleep

NCT00704496

COMPLETED Phase 3

Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT)

NCT00495157

TERMINATED Phase 1

Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation

NCT00626626

TERMINATED Phase 2

Trial of Sunitinib for Refractory Malignant Ascites

NCT00796861

COMPLETED Phase 3

Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)

NCT00395304

COMPLETED NA

Analgesic Properties of Oral Sucrose During Immunizations

NCT00446875

COMPLETED NA

Individually Tailored Web-Based Program to Improve Blood Pressure Control

NCT00377208

COMPLETED Phase 3

(CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)

NCT00394329

TERMINATED Phase 1

Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism

NCT00325572

COMPLETED Phase 3

Improving Health Outcomes for New Mothers and Babies

NCT00360204

COMPLETED Phase 2

The Effects of Naltrexone on Active Crohn's Disease

NCT00663117

COMPLETED Phase 3

DYNAMIC Study: (Diabetes Nurse Case Management And Motivational Interviewing for Change)

NCT00308386

TERMINATED NA

Weaning From Mechanical Ventilation Using Permissive Hypercarbia

NCT00357929

COMPLETED Phase 3

Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA)

NCT00318708

COMPLETED Phase 1

The SLeeping and Intake Methods Taught to Infants and Mothers Early in Life (SLIMTIME) Project

NCT00359242

TERMINATED

Mechano-physiological Approach to Anorectal Function

NCT00219518

TERMINATED NA

Treatment of Rhinitis With Intranasal Vitamin E

NCT00281307

COMPLETED NA

Strength Training Intervention for Breast Cancer Survivors and the Effects on Lymphedema Status

NCT00194363

COMPLETED Phase 3

Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL)

NCT00712985

COMPLETED

Role of Esophageal Mast Cell Activation in Noncardiac Chest Pain (NCCP)

NCT00219492

COMPLETED

The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction

NCT00284960

TERMINATED

Obesity and Weight Loss on Reproductive Function

NCT00143078

COMPLETED Phase 1

Computerized Health Education to Promote Physical Activity

NCT00242658

COMPLETED Phase 1

Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors

NCT00112645

TERMINATED NA

Ultrasound and Endometrial Hyperplasia

NCT00123188

COMPLETED Phase 2

A Trial of Lipitor (Atorvastatin) for the Treatment of Polycystic Ovary Syndrome (PCOS) in Women With Elevated Low-density Lipoprotein (LDL) Cholesterol

NCT00529542

COMPLETED Phase 3

Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE)

NCT00200967

COMPLETED Phase 2

Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS)

NCT00151411

COMPLETED NA

Utilization of Oral Sucrose to Decrease Pain in Infants During Immunizations

NCT00150189

COMPLETED Phase 2

Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

NCT00109941

COMPLETED

Intraoperative Angioembolization in the Management of Pelvic Fracture-Related Hemodynamic Instability

NCT00755365

COMPLETED NA

Assessment and Treatment of Social Skills Deficits in Individuals With Social Phobia

NCT00073333

COMPLETED

Prevalence of Sleep-Disordered Breathing in Children

NCT00022789

COMPLETED

The Effects of Continuous Administration of a Monophasic Oral Contraceptive on Bleeding Days and Endometrial and Ovarian Function

NCT00128726

COMPLETED Phase 1

Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women

NCT01340521

← Previous Page 8 of 8

Phase Distribution

PhaseTrial count
Phase 1 40
Phase 2 33
Phase 3 25
Phase 4 21

What is open in the Milton S. Hershey Medical Center pipeline

55 recruiting of 396 indexed (14% open); 255 completed (64%).

Phase mix: 46 late (III/IV) vs 73 early (I/II) (early-phase heavy).

Top condition: Child Abuse (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Milton S. Hershey Medical Center: open-pipeline peers nationwide

Peers matched on 396 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Milton S. Hershey Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 10%12%14%16%18%20% Total trials Recruiting share Milton S. Hershey Medical CenterAbramson Cancer Center at Penn MedicineCase Comprehensive Cancer CenterUniversity of NebraskaTakedaUniversity of CincinnatiJohns Hopkins Bloomberg School of Public HealthBeiGeneSeattle Institute for Biomedical and Clinical Research
Milton S. Hershey Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Milton S. Hershey Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 396 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this Milton S. Hershey Medical Center page

396 registered trials is a research-attention snapshot, not an endorsement of Milton S. Hershey Medical Center or any single study.

  • 55 of Milton S. Hershey Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Child Abuse is the condition Milton S. Hershey Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Child Abuse trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Milton S. Hershey Medical Center pipeline card: 396 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.